C. Sukasem

发表

P2Y6 receptors are involved in mediating the effect of inactivated avian influenza virus H5N1 on IL-6 & CXCL8 mRNA expression in respiratory epithelium

N. Huipao, S. Borwornpinyo, Suwimon Wiboon-ut, 2017, PloS one.

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population

C. Sukasem, W. Tassaneeyakul, U. Intusoma, 2017, Front. Pharmacol..

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population

C. Sukasem, W. Tassaneeyakul, T. Jantararoungtong, 2017, Pharmacogenetics and genomics.

Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients

W. Aekplakorn, C. Sukasem, T. Jantararoungtong, 2018, Journal of immunology research.

CYP2D6 genotype analysis of a Thai population: platform comparison.

A. Gaedigk, C. Sukasem, A. Puangpetch, 2018, Pharmacogenomics.

Using of nevirapine is associated with intermediate and reduced response to etravirine among HIV-infected patients who experienced virologic failure in a resource-limited setting.

W. Chantratita, C. Sukasem, S. Kiertiburanakul, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Whole-Exome Sequencing Identifies One De Novo Variant in the FGD6 Gene in a Thai Family with Autism Spectrum Disorder

W. Chantratita, P. Limprasert, C. Sukasem, 2018, International journal of genomics.

Qualitative detection of avian influenza A (H5N1) viruses: a comparative evaluation of four real-time nucleic acid amplification methods.

W. Chantratita, O. Landt, T. Songserm, 2008, Molecular and cellular probes.

Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation

C. Sukasem, A. Ingsathit, S. Vadcharavivad, 2018, Therapeutic drug monitoring.

Determination of irinotecan, SN‐38 and SN‐38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients

C. Sukasem, T. Reungwetwattana, A. Puangpetch, 2018, Journal of clinical laboratory analysis.

Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen

C. Sukasem, P. Supavilai, D. Pinthong, 2013, Pharmacogenomics and personalized medicine.

Impact of CYP2D6 polymorphisms on tamoxifen responses of women with breast cancer: a microarray-based study in Thailand.

C. Sukasem, T. Ativitavas, E. Sirachainan, 2012, Asian Pacific journal of cancer prevention : APJCP.

CYP 2 D 6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients

C. Sukasem, T. Ativitavas, E. Sirachainan, 2012 .

CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients

C. Sukasem, T. Ativitavas, E. Sirachainan, 2012, Pharmacogenomics and personalized medicine.

Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia

C. Sukasem, A. Puangpetch, M. Kroll, 2019, Pharmacogenomics and personalized medicine.

An integrated bioinformatics approach to the characterization of influenza A/H5N1 viral sequences by microarray data: Implication for monitoring H5N1 emerging strains and designing appropriate influenza vaccines.

W. Chantratita, J. Zwang, C. Sukasem, 2010, Molecular and cellular probes.

Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population

C. Sukasem, T. Reungwetwattana, D. Muntham, 2017, OncoTargets and therapy.

Impact of Pharmacogenetic Markers of CYP2B6, Clinical Factors, and Drug-Drug Interaction on Efavirenz Concentrations in HIV/Tuberculosis-Coinfected Patients

C. Sukasem, W. Manosuthi, S. Sungkanuparph, 2012, Antimicrobial Agents and Chemotherapy.

ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen.

C. Sukasem, W. Manosuthi, S. Sungkanuparph, 2014, The Journal of antimicrobial chemotherapy.

Pharmacogenetics and Clinical Risk Factors for Risperidone- Related Weight Gain in Thai Autistic Spectrum Disorder Patients

C. Sukasem, A. Puangpetch, Sadeep Medhasi, 2014 .

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis

C. Sukasem, M. Biswas, J. Shobana, 2022, Clinical and translational science.

The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand

C. Sukasem, A. Puangpetch, S. Kiertiburanakul, 2015, Pharmacogenomics and personalized medicine.

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study

C. Sukasem, A. Thakkinstian, A. Puangpetch, 2016, PloS one.

Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report

C. Sukasem, A. Puangpetch, Teerarat Tan-kam, 2013, Pharmacogenomics and personalized medicine.

CEOR_A_366906 447..463

C. Sukasem, Jiraphun Jittikoon, S. Mahasirimongkol, 2022 .

SJS/TEN 2019: From science to translation.

S. Volpi, B. Carleton, M. Pirmohamed, 2020, Journal of dermatological science.

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics

C. Sukasem, T. Tempark, Patompong Satapornpong, 2022, Frontiers in Pharmacology.

Development of Pyrosequencing Method for UGT 1 A 1 Polymorphisms in Thai Colorectal Cancer

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2013 .

CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2013, Pharmacogenomics and personalized medicine.

CYP2B6 18492T→C Polymorphism Compromises Efavirenz Concentration in Coinfected HIV and Tuberculosis Patients Carrying CYP2B6 Haplotype *1/*1

C. Sukasem, W. Manosuthi, S. Sungkanuparph, 2014, Antimicrobial Agents and Chemotherapy.

CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy.

C. Sukasem, W. Manosuthi, S. Sungkanuparph, 2014, International journal of antimicrobial agents.

Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand

W. Chantratita, C. Sukasem, S. Kiertiburanakul, 2012, Journal of the International AIDS Society.

Pharmacogenetics of Risperidone‐Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2018, Basic & clinical pharmacology & toxicology.

PGPM_A_210770 155..166

C. Sukasem, M. Kroll, S. Vanavanan, 2019 .

Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder.

C. Sukasem, A. Puangpetch, Sadeep Medhasi, 2017, Journal of child and adolescent psychopharmacology.

CYP2D6 polymorphisms and their influence on risperidone treatment

C. Sukasem, A. Puangpetch, Monpat Chamnanphon, 2016, Pharmacogenomics and personalized medicine.

Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen

W. Noonpakdee, W. Chantratita, C. Sukasem, 2013, Pharmacogenomics and personalized medicine.

Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.

C. Sukasem, W. Tassaneeyakul, A. Puangpetch, 2014, Asian Pacific journal of allergy and immunology.

Genetic polymorphisms of HTR2C, LEP and LEPR on metabolic syndromes in patients treated with atypical antipsychotic drugs

C. Sukasem, N. Koomdee, A. Puangpetch, 2018, The Journal of pharmacy and pharmacology.

Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV

C. Sukasem, Jiraphun Jittikoon, S. Mahasirimongkol, 2022, ClinicoEconomics and outcomes research : CEOR.

Development and validation of a reliable method for thiopurine methyltransferase (TPMT) enzyme activity in human whole blood by LC–MS/MS: An application for phenotypic and genotypic correlations

S. Pakakasama, C. Sukasem, Nuttawut Jenjirattithigarn, 2017, Journal of pharmaceutical and biomedical analysis.

Comparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug Reactions

P. Limprasert, C. Sukasem, Kanoot Jaruthamsophon, 2016, PloS one.

Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis

C. Sukasem, M. Biswas, Natchaya Vanwong, 2021, Clinical and translational science.

Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy

C. Sukasem, T. Reungwetwattana, A. Puangpetch, 2020, Scientific Reports.

Correlation of UGT1A1(*)28 and (*)6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients.

C. Sukasem, T. Reungwetwattana, A. Puangpetch, 2016, Drug metabolism and pharmacokinetics.

Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2017, Front. Pharmacol..

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2020, Frontiers in Pharmacology.

Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients

C. Sukasem, T. Reungwetwattana, A. Puangpetch, 2022, Frontiers in oncology.

Small-dense LDL cholesterol/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients.

W. Chantratita, C. Sukasem, S. Santon, 2013, American journal of clinical pathology.

Screening of SLC25A13 mutation in the Thai population.

W. Aekplakorn, L. T. Jensen, C. Sukasem, 2013, World journal of gastroenterology.

Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population

C. Sukasem, T. Jantararoungtong, A. Puangpetch, 2022, BMC Pediatrics.

Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics.

G. Patrinos, W. Chantratita, T. Katsila, 2018, Annual review of genomics and human genetics.

Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings.

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2021, Drug metabolism and pharmacokinetics.

Serum Prolactin level in Thai Children and Adolescents with Autistic Spectrum Disorder on Long Term Risperidone Treatments

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2014 .

Would a CYP2B6 test help HIV patients being treated with efavirenz?

C. Sukasem, S. Sungkanuparph, 2013, Pharmacogenomics.

High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections.

W. Chantratita, C. Sukasem, W. Manosuthi, 2013, Drug metabolism and pharmacokinetics.

Pharmacogenetic Study of 5-Fluorouracil-Related Severe Toxicity in Thai Cancer Patients: A Novel SNP Detection

C. Sukasem, T. Reungwetwattana, T. Ativitavas, 2012 .

TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia

S. Pakakasama, C. Sukasem, T. Jantararoungtong, 2021, Journal of personalized medicine.

Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients

A. Gaedigk, C. Sukasem, W. Manosuthi, 2021, Pharmacogenomics and personalized medicine.

PGPM_A_306358 915..926

A. Gaedigk, C. Sukasem, W. Manosuthi, 2021 .

Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes

G. Snounou, S. Krudsood, C. Sukasem, 2017, Malaria Journal.

Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients

C. Sukasem, J. Pratoomwun, A. Puangpetch, 2016, Front. Pharmacol..

NUDT15 genetic variants are related to thiopurine-induced neutropenia in Thai children with acute lymphoblastic leukemia.

S. Pakakasama, C. Sukasem, A. Puangpetch, 2020, Pharmacogenomics.

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population

C. Sukasem, C. Dejthevaporn, P. Srisawasdi, 2020, Frontiers in Pharmacology.

High Efficacy of Primaquine Treatment for Plasmodium vivax in Western Thailand.

R. Longley, W. Nguitragool, J. Sattabongkot, 2016, The American journal of tropical medicine and hygiene.

Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9‐Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2016, Journal of clinical laboratory analysis.

Development and Validation of Voriconazole Concentration by LC‐MS‐MS: Applied in Clinical Implementation

C. Sukasem, Nuttawut Jenjirattithigarn, T. Jantararoungtong, 2017, Journal of clinical laboratory analysis.

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

S. Mallal, J. Struewing, B. Carleton, 2018, The journal of allergy and clinical immunology. In practice.

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine

W. Chantratita, R. Longley, J. Sattabongkot, 2020, Pharmacogenomics and personalized medicine.

PGPM_A_201007 1..12

W. Chantratita, R. Longley, J. Sattabongkot, 2020 .

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

T. Rungrotmongkol, C. Sukasem, M. Biswas, 2022, Frontiers in Pharmacology.

Development and validation of a liquid chromatography-tandem mass spectrometry method for determination of ibuprofen in human plasma

C. Sukasem, A. Puangpetch, S. Prommas, 2020, Clinical Mass Spectrometry.

A LC/MS/MS method for determination of tenofovir in human plasma and its application to toxicity monitoring.

C. Sukasem, A. Puangpetch, D. Pinthong, 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder

B. Wilffert, A. Gaedigk, C. Sukasem, 2021, Frontiers in Pharmacology.

A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study

C. Sukasem, A. Puangpetch, S. Kiertiburanakul, 2015, Pharmacogenomics and personalized medicine.

Pharmacogenetics and clinical biomarkers for subtherapeutic plasma efavirenz concentration in HIV-1 infected Thai adults.

C. Sukasem, W. Manosuthi, T. Jantararoungtong, 2014, Drug metabolism and pharmacokinetics.

Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism

C. Sukasem, W. Manosuthi, T. Jantararoungtong, 2014, Infection.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy

M. Whirl‐Carrillo, L. Gong, T. Klein, 2019, Clinical pharmacology and therapeutics.

Clinical Pharmacogenomics and Personalized Medicine: New Strategies to Maximize Drug Efficacy and Avoid Adverse Drug Reaction

C. Sukasem, Sadeep Medhasi, 2018 .

Development of Pyrosequencing Method for Detection of UGT1A1 Polymorphisms in Thai Colorectal Cancers

C. Sukasem, A. Puangpetch, Chalirmporn Atasilp, 2016, Journal of clinical laboratory analysis.

Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations

C. Sukasem, W. Tassaneeyakul, A. Puangpetch, 2021, Frontiers in Pharmacology.

Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia

C. Sukasem, Y. Vorasettakarnkij, Sadeep Medhasi, 2022, Pharmacogenomics and personalized medicine.

Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder

C. Sukasem, A. Puangpetch, Sadeep Medhasi, 2016, Neuropsychiatric disease and treatment.

Neuropsychiatric Disease and Treatment Dovepress Clinically Relevant Genetic Variants of Drug- Metabolizing Enzyme and Transporter Genes Detected in Thai Children and Adolescents with Autism Spectrum Disorder Sadeep Medhasi Natchaya Vanwong Montri Chamnanphon Yaowaluck Hongkaew Penkhae Limsila

C. Sukasem, A. Puangpetch, Sadeep Medhasi, 2022 .

HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients

M. Pirmohamed, T. Rungrotmongkol, D. Naisbitt, 2021, Frontiers in Immunology.

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics

W. Aekplakorn, Chumpol Ngamphiw, S. Tongsima, 2020, Frontiers in Pharmacology.

HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2016, Front. Pharmacol..

Genetic Association of Co‐Trimoxazole‐Induced Severe Cutaneous Adverse Reactions Is Phenotype‐Specific: HLA Class I Genotypes and Haplotypes

M. Pirmohamed, W. Chantratita, C. Sukasem, 2020, Clinical pharmacology and therapeutics.

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

M. Whirl‐Carrillo, T. Klein, B. Carleton, 2018, Clinical pharmacology and therapeutics.

HLA Allele-Restricted Immune-Mediated Adverse Drug Reactions: Framework for Genetic Prediction.

M. Pirmohamed, D. Naisbitt, C. Sukasem, 2021, Annual review of pharmacology and toxicology.

Whole Genome Sequencing Identifies Genetic Variants Associated with Co-trimoxazole Hypersensitivity in Asians.

Yen‐Hua Huang, W. Chantratita, Yun-Shien Lee, 2020, The Journal of allergy and clinical immunology.

SURVEILLANCE OF HIV-1 DRUG-RESISTANCE MUTATIONS IN THAILAND FROM 1999 TO 2014.

W. Chantratita, C. Sukasem, E. Pasomsub, 2017, The Southeast Asian journal of tropical medicine and public health.

Effect of GSTA1 Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians

S. Pakakasama, C. Sukasem, M. Biswas, 2022, Pharmaceutics.

Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults.

W. Chantratita, C. Sukasem, T. Jantararoungtong, 2012, British journal of clinical pharmacology.

Discrepancies between WHO 2009 and IAS-USA 2009 lists for determining the rate of transmitted HIV-1 drug resistance: a prospective study.

W. Chantratita, C. Sukasem, S. Kiertiburanakul, 2012, Journal of acquired immune deficiency syndromes.

Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.

M. Tiensuwan, W. Chantratita, C. Sukasem, 2007, Japanese journal of infectious diseases.

Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections

C. Sukasem, T. Jantararoungtong, A. Puangpetch, 2020, Pharmacology research & perspectives.

Tipranavir resistance associated mutations in protease inhibitor-naïve patients with HIV-1 subtype A/E infection.

W. Chantratita, C. Sukasem, W. Manosuthi, 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2015, Front. Genet..

Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions

C. Sukasem, T. Rerkpattanapipat, T. Tempark, 2017, European Journal of Clinical Pharmacology.

A Novel Allele-Specific PCR Protocol for the Detection of the HLA-C*03:02 Allele, a Pharmacogenetic Marker, in Vietnamese Kinh People

C. Sukasem, Quang Binh Tran, Thanh Huong Phung, 2021, The application of clinical genetics.

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine

C. Sukasem, M. Biswas, N. Koomdee, 2021, Pharmaceuticals.

Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions

C. Sukasem, N. Musa, M. Sabbah, 2021, Journal of personalized medicine.

Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01

M. Pirmohamed, D. Naisbitt, C. Sukasem, 2021, Frontiers in Immunology.

HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians

Yoshiro Saito, C. Sukasem, W. Tassaneeyakul, 2018, Clinical pharmacology and therapeutics.

Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population

S. Tiamkao, C. Sukasem, Thachanan Kongpan, 2016, Pharmacogenetics and genomics.

Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and Phenytoin-Induced Cutaneous Adverse Drug Reactions in the South Indian Tamil Population

C. Sukasem, K. Balakrishnan, B. Canyuk, 2021, Journal of personalized medicine.

Pharmacogenomics and Efficacy of Risperidone Long‐Term Treatment in Thai Autistic Children and Adolescents

B. Wilffert, C. Sukasem, A. Puangpetch, 2017, Basic & clinical pharmacology & toxicology.

Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2021, Scientific Reports.

Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder.

C. Sukasem, M. Biswas, Natchaya Vanwong, 2022, Pharmacogenomics.

Resolving discordant CYP2D6 genotyping results in Thai: platform limitations and novel haplotypes.

A. Gaedigk, C. Sukasem, R. Gaedigk, 2021, Pharmacogenomics.

Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone

B. Wilffert, A. Gaedigk, C. Sukasem, 2021, Scientific Reports.

UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder

B. Wilffert, C. Sukasem, A. Puangpetch, 2018, The Pharmacogenomics Journal.

Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders.

C. Sukasem, A. Puangpetch, M. Kroll, 2017, Clinical biochemistry.

Pharmacogenomics in Asians: Differences and similarities with other human populations

C. Sukasem, M. Biswas, Pimonpan Jinda, 2023, Expert opinion on drug metabolism & toxicology.

Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels.

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2016, Drug metabolism and pharmacokinetics.

Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation

C. Sukasem, A. Ingsathit, S. Vadcharavivad, 2015, European Journal of Clinical Pharmacology.

Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives

W. Chantratita, T. M. Hlaing, R. Yuliwulandari, 2019, Public Health Genomics.

A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis.

C. Sukasem, T. Jantararoungtong, A. Puangpetch, 2016, Drug metabolism and pharmacokinetics.

A success story in pharmacogenomics: genetic ID card for SJS/TEN.

Wasun Chantratita, W. Chantratita, C. Sukasem, 2016, Pharmacogenomics.

Molecular genetic analysis of CYP2D6 and HLA-B*15:02 in Thai autistic spectrum disorder children: Implication for pharmacogenetics testing and optimization of drug treatments

C. Sukasem, A. Puangpetch, M. Chamnanphon, 2013 .

HLA Class II-restricted CD8+ T cells contribute to the promiscuous immune response in dapsone hypersensitive patients.

M. Pirmohamed, Jianjun Liu, Hong Liu, 2021, The Journal of investigative dermatology.

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

C. Sukasem, M. Biswas, T. Jantararoungtong, 2022, Frontiers in Pharmacology.

Pharmacogenomics: A New Approach for Preventing Severe Cutaneous Adverse Drug Reactions

C. Sukasem, T. Tempark, 2018 .

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin

C. Sukasem, M. Kroll, C. Dejthevaporn, 2021, Pharmacogenomics and Personalized Medicine.

PGPM_A_278671 1..13

C. Sukasem, M. Kroll, C. Dejthevaporn, 2021 .

Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.

K. Chanprapaph, C. Sukasem, J. Klaewsongkram, 2019, The journal of allergy and clinical immunology. In practice.

HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis

P. Limprasert, C. Sukasem, Kanoot Jaruthamsophon, 2017, Scientific Reports.

Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians

T. Kuo, R. Hui, C. Sukasem, 2017, Neurology.

Comparison between the HLA-B∗58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions

C. Sukasem, S. Kanjanawart, Usanee Khunarkornsiri, 2017, Journal of immunology research.

The Role of In Vitro Detection of Drug-Specific Mediator-Releasing Cells to Diagnose Different Phenotypes of Severe Cutaneous Adverse Reactions

K. Chanprapaph, C. Sukasem, T. Rerkpattanapipat, 2021, Allergy, asthma & immunology research.

In vitro test to confirm diagnosis of allopurinol‐induced severe cutaneous adverse reactions

K. Chanprapaph, C. Sukasem, J. Klaewsongkram, 2016, The British journal of dermatology.

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2021, Expert opinion on drug metabolism & toxicology.

Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population

K. Sawanyawisuth, C. Sukasem, W. Tassaneeyakul, 2017, Pharmacogenetics and genomics.

Title : In Vitro Test to Confirm Diagnosis of Allopurinol-Induced Severe Cutaneous Adverse Reactions Running title : In Vitro Test for Allopurinol-Induced Severe Cutaneous Adverse Reactions

Y., T., Ľ., 2016 .

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand

C. Sukasem, M. Biswas, T. Jantararoungtong, 2022, Frontiers in Pharmacology.

Significant Association of HLA-B Alleles and Genotypes in Thai Children with Autism Spectrum Disorders: A Case-Control Study

C. Sukasem, N. Koomdee, A. Puangpetch, 2015, Disease markers.

Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis

W. Aekplakorn, T. Rungrotmongkol, C. Sukasem, 2021, The Pharmacogenomics Journal.

Effect of 5‐HT2C receptor gene polymorphism (HTR2C−759C/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2021, Pharmacoepidemiology and drug safety.

Genetic and clinical risk factors associated with phenytoin‐induced cutaneous adverse drug reactions in Thai population

C. Sukasem, J. Klaewsongkram, T. Rerkpattanapipat, 2020, Pharmacoepidemiology and drug safety.

Reliability and validity of the Thai Drug Hypersensitivity Quality of Life Questionnaire: a multi-center study.

K. Chanprapaph, C. Sukasem, I. Baiardini, 2018, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Pharmacokinetics of mitragynine in man

Korbtham Sathirakul, S. Auparakkitanon, C. Sukasem, 2015, Drug design, development and therapy.

Associations of the SREBF2 Gene and INSIG2 Polymorphisms with Obesity and Dyslipidemia in Thai Psychotic Disorder Patients Treated with Risperidone

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2021, Journal of personalized medicine.

Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine

C. Sukasem, M. Biswas, J. Shobana, 2023, Expert opinion on drug metabolism & toxicology.

Molecular epidemiology of human papillomavirus genotype in women with high‐grade squamous intraepithelial lesion and cervical cancer: Will a quadrivalent vaccine be necessary in Thailand?

W. Chantratita, C. Sukasem, P. Junyangdikul, 2011, Journal of medical virology.

Characterization of Drug-Specific CD4+ T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions

M. Pirmohamed, D. Naisbitt, A. Alfirevic, 2023, Chemical research in toxicology.

The measurement of drug‐induced interferon γ‐releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions

K. Chanprapaph, C. Sukasem, J. Klaewsongkram, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients

M. Pirmohamed, D. Naisbitt, C. Sukasem, 2022, Chemical research in toxicology.

Exome Sequencing Identifies Compound Heterozygous Mutations in SCN5A Associated with Congenital Complete Heart Block in the Thai Population

W. Chantratita, P. Limprasert, C. Sukasem, 2016, Disease markers.

9‐Hydroxyrisperidone‐Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2016, Basic & clinical pharmacology & toxicology.

Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2016, Journal of clinical psychopharmacology.

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone

C. Sukasem, A. Puangpetch, Natchaya Vanwong, 2015, Neuropsychiatric disease and treatment.

UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder

B. Wilffert, C. Sukasem, A. Puangpetch, 2018, The Pharmacogenomics Journal.

CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia

A. Gaedigk, C. Sukasem, Monpat Chamnanphon, 2020, Pharmacogenomics and personalized medicine.

PGPM_A_276230 543..551

A. Gaedigk, C. Sukasem, Monpat Chamnanphon, 2020 .

Surveillance of Genotypic Resistance Mutations in Chronic HIV-1 Treated Individuals After Completion of the National Access to Antiretroviral Program in Thailand

W. Chantratita, M. Tiensuwan, W. Chantratita, 2007, Infection.

Clinical performance of three rapid diagnostic tests for influenza virus in nasopharyngeal specimens to detect novel swine-origin influenza viruses

W. Chantratita, C. Sukasem, V. Pongthanapisith, 2011, Infection.

ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen

C. Sukasem, P. Supavilai, D. Pinthong, 2016, OncoTargets and therapy.

Comparison of protease inhibitor (PI) resistance-associated mutations between PI-naïve and PI-experienced HIV-1 infected patients in Thailand where subtype A/E is predominant.

W. Chantratita, C. Sukasem, S. Sungkanuparph, 2010, Current HIV research.

Estimation of plasma small dense LDL cholesterol from classic lipid measures.

C. Sukasem, M. Kroll, S. Vanavanan, 2011, American journal of clinical pathology.

Prevalence of Antiretroviral Drug Resistance in Treated HIV-1 Infected Patients: Under the Initiative of Access to the NNRTI-Based Regimen in Thailand

M. Tiensuwan, W. Chantratita, C. Sukasem, 2007, Journal of chemotherapy.

Dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus

K. Chanprapaph, Preeyachat Limtong, P. Suchonwanit, 2021, The Journal of dermatology.

Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis

C. Sukasem, M. Biswas, Sumaiya Khatun Kali, 2023, Expert opinion on drug safety.

Emotional Impact of Premature Aging Symptoms in Long-Term Treated

W. Chantratita, C. Sukasem, S. Kiertiburanakul, 2012 .

Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.

K. Ruxrungtham, C. Sukasem, A. Avihingsanon, 2017, Pharmacogenomics.

Simplified and Rapid Determination of Primaquine and 5,6-Orthoquinone Primaquine by UHPLC-MS/MS: Its Application to a Pharmacokinetic Study

C. Sukasem, M. Mungthin, S. Wittayalertpanya, 2021, Molecules.

Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine.

D. Richman, Davey M. Smith, W. Chantratita, 2010, AIDS research and human retroviruses.

7th Drug hypersensitivity meeting: part two

S. Mallal, A. Borobia, P. Korošec, 2016, Clinical and Translational Allergy.

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations

G. Patrinos, L. Quiñones, C. Sukasem, 2023, Frontiers in Pharmacology.

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam

C. Sukasem, Q. N. Nguyen, Ai-Hoc Nguyen, 2023, Frontiers in pharmacology.

Toxic epidermal necrolysis after first dose of Pfizer‐BioNTech (BNT162b2) vaccination with pharmacogenomic testing

C. Sukasem, T. Tempark, Nunthana Siripipattanamongkol, 2022, Pediatric dermatology.

Would a CYP2B6 test help HIV patients being treated with efavirenz?

C. Sukasem, S. Sungkanuparph, 2013, Pharmacogenomics (London).

Comparison between the HLA-B∗58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions

C. Sukasem, S. Kanjanawart, W. Tassaneeyakul, 2017, Journal of immunology research.

Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand.

C. Sukasem, W. Tassaneeyakul, N. Chaiyakunapruk, 2023, Journal of medical economics.

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

M. Whirl‐Carrillo, T. Klein, B. Carleton, 2018, Clinical pharmacology and therapeutics.

Determination of plasma Levetiracetam level by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS) and its application in pharmacokinetics studies in neonates.

C. Sukasem, Nuttawut Jenjirattithigarn, A. Puangpetch, 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.

M. Tiensuwan, W. Chantratita, C. Sukasem, 2008, International journal of antimicrobial agents.

Clinical pharmacogenomics implementation in Thailand: a dream come true.

C. Sukasem, M. Biswas, P. Lungchukiet, 2023, Pharmacogenomics.

The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine

S. Tongsima, C. Sukasem, Patompong Satapornpong, 2024, The application of clinical genetics.

Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications

C. Sukasem, M. Biswas, N. Vanwong, 2024, Frontiers in pharmacology.

Effects of CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: meta-analysis.

C. Sukasem, M. Biswas, Baharuddin Ibrahim, 2022, Pharmacogenomics.

Polymorphisms of the ApoE (Apolipoprotein E) gene and their influence on dyslipidemia in HIV-1-infected individuals.

W. Chantratita, C. Sukasem, N. Koomdee, 2015, Japanese journal of infectious diseases.